Last Updated:
Name Designation Appointment Date Status
Payal Paresh Bagadia

Appointed as Director since December 2023

 Director 26-Dec-2023 Current
Premium access

Complete director details

Unlock the complete director and KMP records available for Apexio Pharma Private Limited.

  • Complete appointment and designation records
  • Current and past company associations
  • Shareholding and remuneration where filed

Verified entity values are shown only after access is granted.
Aarti Rohitash Maheshwari

Appointed as Director since December 2023

 Director 26-Dec-2023 Current
Paresh Shantilal Bagadia

Appointed as Director since December 2023

 Director 26-Dec-2023 Current
Chenthanmara Kp Nair

Appointed as Director since December 2023

 Director 26-Dec-2023 Current

People Timeline

Explore the timeline of key personnel in Apexio Pharma Private Limited's leadership journey.

Contact Details
  • Address 501, Anjani Complex, Pereira Hill Rd,Andheri E, Mumbai Maharashtra, 400093, India
  • Telephone Upgrade
  • Email Upgrade
  • Pin Code 400093
  • Country India
  • Website -
Frequently Asked Questions
You can contact Apexio Pharma Private Limited through their registered address at 501, Anjani Complex, Pereira Hill Rd,Andheri E, Mumbai Maharashtra, 400093, India, or via their website if available. Social media links are also provided where applicable.
The current directors of Apexio Pharma Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • Payal Paresh Bagadia
  • Aarti Rohitash Maheshwari
  • PARESH SHANTILAL BAGADIA
  • CHENTHANMARA KP NAIR
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available